Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and efficacy of once-daily
topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel
in subjects with inflammatory acne vulgaris